cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.25934/00002821
title: A Phase 1, Double-Blind, Placebo-Controlled, Two-way Crossover Study to Assess the Effect of Multiple Oral Doses of 90 mg Dexlansoprazole MR on the Pharmacokinetics of Phenytoin Following a Single Oral Dose of 250 mg Phenytoin

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002820
title: A Phase 1 Two-Way Crossover Study to Assess the Effect of Multiple Oral Doses of Dexlansoprazole MR (TAK-390MR) on the Single Oral Dose Pharmacokinetics and Pharmacodynamics of Warfarin

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002815
title: A Phase 1, Randomized, Open-Label, Crossover, Single Center Study to Measure Plasma Gastrin Levels Following Administration of 90-mg and 120-mg Oral Doses of a Modified-Release Formulation of TAK-390 and a 30-mg Oral Dose of Lansoprazole in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002814
title: A Phase 1, Randomized, Double-Blind, Four-Period Crossover Study to Assess the Effects on the Cardiac QT Interval of a Single Dose of TAK-390MR (90 mg and 300 mg) with a Placebo Control and Avelox® 400 mg as an Active Control in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002812
title: A Phase 1, Randomized, Open-Label, Single-Dose, Four-Period Crossover Study Comparing the Pharmacokinetics of a 90 mg Modified-Release TAK-390 Formulation Administered Orally Under Fed and Fasting Conditions in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002811
title: A Multiple-Dose Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral TMX-67 in Healthy Volunteers

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00003359
title: A Phase 1, Open Label, Four-Way, Parallel Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of Febuxostat after Multiple Oral Doses of Three Prototype Extended Release Febuxostat Formulations versus Immediate Release 80 mg Tablet Formulation

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00003358
title: A Phase 1, Open Label, Five-Way Crossover Study to Compare the Bioavailability, Pharmacokinetics, and Safety of Febuxostat After Single Oral Doses of Immediate Release and Bimodal Release Febuxostat 80 mg Tablet Formulations

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.15468/dl.kf9xr4
title: Occurrence Download

description: A dataset containing 636 species occurrences available in GBIF matching the query:
{
 "DatasetKey" : [
 "is Coleção de Mastofauna do Museu de Ciências Univates"
 ]
}

 The dataset includes 636 records from 1 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002314-241125135418005/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25934/00003357
title: A Phase 1, Open-Label, Randomized, 5-Way Crossover Study to Compare the Bioavailability, Pharmacokinetics, and Safety of Febuxostat After Single Oral Doses of Febuxostat 80 mg Immediate Release Tablet and Multiparticulate 80 mg Capsule Formulations

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.15468/dl.62dvrh
title: Occurrence Download

description: A dataset containing 94 species occurrences available in GBIF matching the query:
{
 "TaxonKey" : [
 "is Cleistogenes chinensis (Maxim.) Keng"
 ]
}

 The dataset includes 94 records from 14 constituent datasets; see https://api.gbif.org/v1/occurrence/download/0002313-241125135418005/datasets/export for details.
 
Data from some individual datasets included in this download may be licensed under less restrictive terms.
DOI: 10.25934/00002810
title: A Phase 1, Double-Blind, Randomized, 2-Period Crossover Study to Evaluate the Effect of Multiple Oral Doses of Febuxostat on the Pharmacokinetics of a Single Oral Dose of Rosiglitazone

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00003356
title: A Phase 1, Pharmacoscintigraphy Study to Assess the Relative Bioavailability of Febuxostat Released in the Proximal Small Intestine, the Distal Small Intestine, and the Colon

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002809
title: A Phase 1, Double-Blind, Randomized, 2-Period Crossover Study to Evaluate the Effect of Multiple Oral Doses of Febuxostat on the Pharmacokinetics of a Single Oral Dose of Theophylline

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002805
title: The Effect of an Antacid on the Pharmacokinetics of TMX-67 in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002800
title: The Effect of Colchicine on the Pharmacokinetic Profile of TMX-67 in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002801
title: Safety, Pharmacokinetics, and Pharmacodynamic Study of TMX-67 in Subjects with Normal or Impaired Renal Function

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00003355
title: The Pharmacokinetic and Pharmacodynamic Study of Oral TMX-67 in Hyperuricemic Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002798
title: A Phase 1, Randomized, Open-Label, Single-Dose, 2-Period Crossover Study to Determine the Absolute Bioavailability of Fasiglifam (TAK-875) in Healthy Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002796
title: A Phase 1, Open-Label, Sequential Design Study to Evaluate the Drug Interaction Potential Between Simvastatin and TAK-875, and Pravastatin and TAK-875 in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002794
title: A Phase 1, Open-Label, Sequential Design Study to Evaluate the Drug Interaction Potential of TAK-875 on Digoxin in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002793
title: A Phase 1, Open-Label, Sequential Design Study to Evaluate the Drug Interaction Potential Between Alogliptin and TAK-875 in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002792
title: A Phase 1, Randomized, Open-Label, Single-Dose, 2-Period Crossover Study to Evaluate the Effects of Food on the Pharmacokinetics of TAK-875 in Healthy Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002791
title: A Phase 1, Open-Label, Sequential Design Study to Evaluate the Drug Interaction Potential Between Metformin and TAK-875 in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002789
title: A Phase 1, Open-Label, Single-Dose Study to Evaluate the Effects of Age and Gender on the Pharmacokinetics of TAK-875 in Healthy Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002790
title: A Phase 1, Open-Label, Multiple-Dose, Sequential Design Study to Evaluate the Effect of Multiple Oral Doses of TAK-875 on the Steady-State Pharmacokinetics and Pharmacodynamics of Ethinyl Estradiol and Levonorgestrel in Healthy Adult Female Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002788
title: A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of a Single Oral Dose of TAK-875 25 mg in Subjects with Normal or Varying Degrees of Impaired Hepatic Function

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002787
title: A Phase 1, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetics and Safety of a Single Oral Dose of TAK-875 50 mg in Subjects with Normal or Varying Degrees of Impaired Renal Function

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002786
title: A Randomized, Double-Blind, Placebo- and Positive-Controlled, 4-Arm Parallel- Group Study to Evaluate the Effect of TAK-875 on the Electrocardiogram in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002785
title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, 2-Sequence Crossover Interaction Study Investigating the Effect of TAK-875 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002782
title: A Phase 1, Open-Label, Sequential Design Study to Evaluate the Effect of Multiple Oral Doses of Ketoconazole on the Pharmacokinetics of a Single Oral Dose of TAK-875 in Healthy Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002783
title: A Phase 1, Open-Label, Sequential Design Study to Evaluate the Effect of Multiple Oral Doses of Pioglitazone on the Pharmacokinetics of a Single Oral Dose of TAK-875 in Healthy Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002781
title: A Phase 1, Open-Label, Sequential Design Study to Evaluate the Effect of Multiple Oral Doses of TAK-875 on the Pharmacokinetics of a Single Oral Dose of Repaglinide in Healthy Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.
DOI: 10.25934/00002780
title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, 2-Sequence Crossover Interaction Study Investigating the Effect of TAK-875 on the Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Adult Subjects

description: Vivli is an independent, non-profit organization that has developed a global data-sharing and analytics platform to serve all elements of the international research community. Our mission is to promote, coordinate, and facilitate scientific sharing and reuse of clinical research data through the creation and implementation of a sustainable global data-sharing enterprise. The Vivli platform includes an independent data repository, in-depth search engine and a cloud-based, secure analytics platform.